Axon Enterprise (AXON) Financials

Axon Enterprise’s latest quarter shows a company still growing quickly, but with a major short-term cash burn tied to acquisitions and working capital. Revenue rose sharply year over year in Q1 2026, while profitability remained solid on an earnings basis. However, operating cash flow turned negative and the balance sheet now carries more leverage than it did a year ago.

Top takeaways for investors:

• Q1 2026 revenue increased to $807.3 million from $603.6 million in Q1 2025, showing strong top-line growth of about 34%.
• Gross profit improved to $477.3 million, up from $365.7 million a year earlier, indicating Axon is scaling its core business well.
• Net income in Q1 2026 was $169.3 million, up from $87.98 million in Q1 2025.
• Diluted EPS rose to $2.05 from $1.08 year over year, a strong earnings improvement.
• At quarter-end, Axon had $458.9 million in cash and equivalents plus $278.1 million in short-term investments, giving it a sizable liquidity cushion.
• Deferred revenue remains meaningful, with $690.4 million current deferred revenue and $362.2 million noncurrent deferred revenue, which supports future revenue recognition.
• The company continues to invest heavily in growth, including $549.7 million in acquisitions during Q1 2026.
• Q1 2026 operating income was only $29.2 million, so profitability at the operating level remains thin relative to revenue.
• Operating cash flow was negative $31.5 million in Q1 2026, down from positive $217.2 million in Q4 2025 and positive $25.8 million in Q1 2025.
• Cash and equivalents fell sharply from $1.42 billion in Q3 2025 to $458.9 million in Q1 2026, largely due to acquisitions and investment activity.
• Long-term debt increased to $1.73 billion from $1.73 billion at the end of 2025 but, more importantly, it remains much higher than the $680.3 million shown at year-end 2024.
• Total liabilities rose to $3.53 billion, while equity was $3.53 billion, suggesting leverage has become a bigger factor in the capital structure.

Longer-term trend: Axon has posted a strong multi-year revenue and earnings expansion, especially through 2024 and into 2025. Revenue has moved from the low-$300 million range in early 2023 to more than $800 million in Q1 2026. That’s a powerful growth story. Still, the latest quarter also shows that growth is being funded aggressively, and the company’s cash generation can be lumpy because of acquisitions, investment swings, and working-capital needs.

Bottom line: Axon’s fundamentals remain growth-oriented and profitable on an accounting basis, but investors should watch two things closely: operating cash flow and balance sheet leverage. If revenue growth continues while cash burn normalizes, the stock could remain compelling. If acquisitions continue to drain liquidity faster than operations replenish it, the risk profile rises.